Frequently Asked Questions
The market is segmented based on Global Paediatric Vaccine Market, By Vaccine Type (Monovalent and Multivalent), Technology (Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate and Other Technologies), Application (Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR) and Other Applications) – Industry Trends and Forecast to 2029.
.
The Global Pediatric Vaccine Market size was valued at USD 35.74 USD Billion in 2021.
The Global Pediatric Vaccine Market is projected to grow at a CAGR of 9.8% during the forecast period of 2022 to 2029.
The major players operating in the market include ,yte, SINOVAC, DAIICHI SANKYO, Astellas Pharma, Novo Nordisk, Pfizer, Johnson & Johnson, Sanofi, Teva Pharmaceutical, Takeda Pharmaceutical, Astrazeneca, Bristol-Myers Squibb, GlaxoSmithKline, F. Hoffmann-La Roche, Novartis, Lily, Abbott, Merck & Co.
.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
